ReviewTherapeutic advances in medical oncology2022

Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?

Caitlin Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.